You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ)2個產品收到藥品再註冊批准通知書
格隆匯 07-04 16:42

格隆匯7月4日丨華森製藥(002907.SZ)公吿,公司於近日收到重慶市藥品監督管理局核准簽發的關於公司六味安神膠囊和注射用布美他尼2個產品的《藥品再註冊批准通知書》。

六味安神膠囊適應症:滋陰清心,化痰安神。用於失眠症中醫辨證屬陰虛火旺夾痰證者,症見失眠、心煩、心悸、易汗、口乾少津、健忘、胸脘痞悶、舌紅苔膩,脈細滑數等。

注射用布美他尼適應症:(1)水腫性疾病包括充血性心力衰竭、肝硬化、腎臟疾病(腎炎、腎病及各種原因所致的急慢性腎功能衰竭),尤其是應用其他利尿藥效果不佳時,應用本類藥物仍可能有效。與其他藥物合用治療急性肺水腫和急性腦水腫等。(2)高血壓。在高血壓的梯度療法中,不作為治療原發性高血壓的首選藥物,但當噻嗪類藥物療效不佳,尤其當伴有腎功能不全或出現高血壓危象時,本類藥物尤為適用。(3)預防急性腎功能衰竭用於各種原因導致腎臟血流灌注不足,例如失水、休克、中毒、麻醉意外以及循環功能不全等,在糾正血容量不足的同時及時應用,可減少急性腎小管壞死的機會。(4)高鉀血癥及高鈣血癥。(5)稀釋性低鈉血癥尤其是當血鈉濃度低於120mmol/L時。(6)抗利尿激素分泌過多症(SIADH)。(7)急性藥物毒物中毒等的治療,如巴比妥類藥物中毒等。(8)對某些呋塞米無效的病例仍可能有效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account